Combination therapy in metastatic renal cell carcinoma

Lancet Oncol. 2011 Jul;12(7):613-4. doi: 10.1016/S1470-2045(11)70146-2. Epub 2011 Jun 12.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols*
  • Bevacizumab
  • Carcinoma, Renal Cell / drug therapy*
  • Humans
  • Interferon-alpha / therapeutic use
  • Neoplasm Metastasis
  • Sirolimus / analogs & derivatives
  • Sirolimus / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interferon-alpha
  • Bevacizumab
  • temsirolimus
  • Sirolimus